Impact of clinical pharmacists intervention on management of hyperglycemia in pregnancy in Jordan

Background and objective Hyperglycemia in pregnancy is a risk factor for cardiovascular disease and postpartum (PP) diabetes. This study aimed to assess the impact of the clinical pharmacist-assisted program (CPAP) of optimizing drug therapy and intensive education on main management outcome measure...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical pharmacy 2018-02, Vol.40 (1), p.48-55
Main Authors: Batta, Razan Adnan, Kasabri, Violet, Akour, Amal, Hyassat, Dana, Albsoul-Younes, Abla
Format: Article
Language:English
Subjects:
Cardiovascular diseases
Complications
Diabetes
Diabetes mellitus
Disease control
Disease management
Health risks
Hyperglycemia
Hypoglycemia
Internal Medicine
Medicine
Medicine & Public Health
Pharmacy
Postpartum
Pregnancy
Pregnancy complications
Quality of life
Research Article
Risk factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and objective Hyperglycemia in pregnancy is a risk factor for cardiovascular disease and postpartum (PP) diabetes. This study aimed to assess the impact of the clinical pharmacist-assisted program (CPAP) of optimizing drug therapy and intensive education on main management outcome measures of patient knowledge about diabetes, Quality of life (QoL) as measured by SF-36 including maternal complications, fasting plasma glucose (FPG) control, and HbA1c. Method This is a randomized controlled study. Pregnant (20–28 weeks) patients with hyperglycemia received CPAP (n = 51) as compared with conventional management (n = 34). Patients were then followed up for 6 weeks pp. Results A significant change was shown in the intervention group for diabetes knowledge (3.47% vs. control 2.03%, P  
ISSN:2210-7703
2210-7711
DOI:10.1007/s11096-017-0550-3